Faron Announces Release of Research Confirming Bexmarilimab Efficacy and Safety in MATINS Trial
FINLAND - Faron Pharmaceuticals Oy , a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, today announces the release of further insights from its Phase... | April 25, 2023